Profile data is unavailable for this security.
About the company
Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.
- Revenue in EUR (TTM)1.22bn
- Net income in EUR216.80m
- Incorporated2006
- Employees3.70k
- LocationOrion OyjOrionintie 1AESPOO 02200FinlandFIN
- Phone+358 104261
- Fax+358 104264435
- Websitehttps://www.orion.fi/
More ▼
9.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Keskin�inen El�kevakuutusyhti� Ilmarinenas of 21 Jun 2023 | 1.85m | 5.56% |
| Keskin�inen Ty�el�kevakuutusyhti� Eloas of 28 Feb 2023 | 292.80k | 0.88% |
| abrdn Investment Management Ltd.as of 31 Jan 2023 | 235.82k | 0.71% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 223.39k | 0.67% |
| Jenny ja Antti Wihurin rahasto sras of 28 Feb 2023 | 123.84k | 0.37% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 103.60k | 0.31% |
| Mercer Global Investments Europe Ltd.as of 31 Dec 2023 | 81.23k | 0.24% |
| Handelsbanken Fonder ABas of 31 Mar 2024 | 57.49k | 0.17% |
| Nordea Investment Management AB (Denmark)as of 29 Feb 2024 | 47.58k | 0.14% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2023 | 45.98k | 0.14% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
